HRT FINANCIAL LP purchased $28K of SHPH
HRT FINANCIAL LP purchased 7,851 shares of Shuttle Pharmaceuticals Holdings, Inc. (SHPH) at $3.54 on 2026-07-02.
How this was made
The 30-second read
Why it matters
Traders may monitor whether this buy is part of a broader accumulation pattern, but the filing alone does not change the company’s operating outlook.
Market read
Fresh Form 4 data (date, shares, price) provides incremental sentiment information, but no fundamental catalyst is disclosed.
What to watch
No 10b5-1 plan is cited, but the filing also provides no rationale, follow-on buying cadence, or linkage to upcoming catalysts (earnings/trial/regulatory).
Background
The article is a SEC Form 4 insider transaction disclosure for Shuttle Pharmaceuticals Holdings, Inc. (SHPH).
Ticker impact
HRT Financial LP filed a Form 4 showing an open-market purchase of 7,851 Shuttle Pharmaceuticals shares at $3.54 on 2026-07-02.
Likely limited near-term impact; may slightly support sentiment if investors track 10% owner activity.
Form 4 provides a fresh, primary-source transaction date/price, but it does not include guidance, trial results, or other company-specific news that would typically drive repricing.
Market effects
No clear sector read-through; this is a single-issuer ownership transaction without new clinical/regulatory information.
None indicated.
None indicated.
Counterpoint
A 10% owner open-market buy can be routine (e.g., liquidity/portfolio rebalancing) and may not signal improved fundamentals.
Key entities
- issuerShuttle Pharmaceuticals Holdings, Inc.
Subject of the Form 4; 10% owner HRT Financial LP reported an open-market purchase.
- 10% ownerHRT Financial LP
Reported purchase of 7,851 SHPH shares at $3.54 on 2026-07-02; filing made 2026-07-07.